Neoadjuvant atezolizumab for resectable non-small cell lung cancer: an open-label, single-arm phase II trial

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1546-170X

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Neoadjuvant atezolizumab for resectable non-small cell lung cancer: an open-label, single-arm phase II trial ; volume:28 ; number:10 ; day:12 ; month:9 ; year:2022 ; pages:2155-2161 ; date:10.2022
Nature medicine ; 28, Heft 10 (12.9.2022), 2155-2161, 10.2022

Creator: Chaft, Jamie E.
Oezkan, Filiz
Kris, Mark G.
Bunn, Paul A.
Wistuba, Ignacio I.
Kwiatkowski, David J.
Owen, Dwight H.
Tang, Yan
Johnson, Bruce E.
Lee, Jay M.
Lozanski, Gerard
Pietrzak, Maciej
Seweryn, Michal
Byun, Woo Yul
Schulze, Katja
Nicholas, Alan
Johnson, Ann
Grindheim, Jessica
Hilz, Stephanie
Shames, David S.
Rivard, Chris
Toloza, Eric
Haura, Eric B.
McNamee, Ciaran J.
Patterson, G. Alexander
Waqar, Saiama N.
Rusch, Valerie W.
Carbone, David P.

Contributor: SpringerLink (Online service)

DOI: 10.1038/s41591-022-01962-5

URN: urn:nbn:de:101:1-2022122921124168465798

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:35 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Chaft, Jamie E.
Oezkan, Filiz
Kris, Mark G.
Bunn, Paul A.
Wistuba, Ignacio I.
Kwiatkowski, David J.
Owen, Dwight H.
Tang, Yan
Johnson, Bruce E.
Lee, Jay M.
Lozanski, Gerard
Pietrzak, Maciej
Seweryn, Michal
Byun, Woo Yul
Schulze, Katja
Nicholas, Alan
Johnson, Ann
Grindheim, Jessica
Hilz, Stephanie
Shames, David S.
Rivard, Chris
Toloza, Eric
Haura, Eric B.
McNamee, Ciaran J.
Patterson, G. Alexander
Waqar, Saiama N.
Rusch, Valerie W.
Carbone, David P.
SpringerLink (Online service)

Other Objects (12)

Author Correction: Neoadjuvant atezolizumab for resectable non-small cell lung cancer: an open-label, single-arm phase II trial

A multicenter, open-label, single-arm phase I trial of neoadjuvant nivolumab monotherapy for resectable gastric cancer

Perioperative sintilimab and neoadjuvant anlotinib plus chemotherapy for resectable non-small-cell lung cancer: a multicentre, open-label, single-arm, phase 2 trial (TD-NeoFOUR trial)

Neoadjuvant relatlimab and nivolumab in resectable melanoma

Adjuvant and Neoadjuvant Treatments for Resectable Hepatocellular Carcinoma

Neoadjuvant radiotherapy for resectable retroperitoneal sarcoma: a meta-analysis

Network meta-analysis comparing neoadjuvant chemoradiation, neoadjuvant chemotherapy and upfront surgery in patients with resectable, borderline resectable, and locally advanced pancreatic ductal adenocarcinoma

Neo-adjuvant chemotherapy plus immunotherapy in resectable N1/N2 NSCLC

Neoadjuvant Chemotherapy Switch in Borderline Resectable/Locally Advanced Pancreatic Cancer

A case study of combined neoadjuvant chemotherapy and neoadjuvant immunotherapy in resectable locally advanced esophageal cancer

Predictive factors of operability after neoadjuvant chemotherapy in resectable or borderline resectable pancreatic cancer: a single-center retrospective study

Preoperative chemotherapy and carbon ions therapy for treatment of resectable and borderline resectable pancreatic adenocarcinoma: a prospective, phase II, multicentre, single-arm study

Author Correction: Neoadjuvant atezolizumab for resectable non-small cell lung cancer: an open-label, single-arm phase II trial

A multicenter, open-label, single-arm phase I trial of neoadjuvant nivolumab monotherapy for resectable gastric cancer

Perioperative sintilimab and neoadjuvant anlotinib plus chemotherapy for resectable non-small-cell lung cancer: a multicentre, open-label, single-arm, phase 2 trial (TD-NeoFOUR trial)

Neoadjuvant relatlimab and nivolumab in resectable melanoma

Adjuvant and Neoadjuvant Treatments for Resectable Hepatocellular Carcinoma

Neoadjuvant radiotherapy for resectable retroperitoneal sarcoma: a meta-analysis

Network meta-analysis comparing neoadjuvant chemoradiation, neoadjuvant chemotherapy and upfront surgery in patients with resectable, borderline resectable, and locally advanced pancreatic ductal adenocarcinoma

Neo-adjuvant chemotherapy plus immunotherapy in resectable N1/N2 NSCLC

Neoadjuvant Chemotherapy Switch in Borderline Resectable/Locally Advanced Pancreatic Cancer

A case study of combined neoadjuvant chemotherapy and neoadjuvant immunotherapy in resectable locally advanced esophageal cancer

Predictive factors of operability after neoadjuvant chemotherapy in resectable or borderline resectable pancreatic cancer: a single-center retrospective study

Preoperative chemotherapy and carbon ions therapy for treatment of resectable and borderline resectable pancreatic adenocarcinoma: a prospective, phase II, multicentre, single-arm study

Author Correction: Neoadjuvant atezolizumab for resectable non-small cell lung cancer: an open-label, single-arm phase II trial

A multicenter, open-label, single-arm phase I trial of neoadjuvant nivolumab monotherapy for resectable gastric cancer

Perioperative sintilimab and neoadjuvant anlotinib plus chemotherapy for resectable non-small-cell lung cancer: a multicentre, open-label, single-arm, phase 2 trial (TD-NeoFOUR trial)

Neoadjuvant relatlimab and nivolumab in resectable melanoma

Adjuvant and Neoadjuvant Treatments for Resectable Hepatocellular Carcinoma

Neoadjuvant radiotherapy for resectable retroperitoneal sarcoma: a meta-analysis

Network meta-analysis comparing neoadjuvant chemoradiation, neoadjuvant chemotherapy and upfront surgery in patients with resectable, borderline resectable, and locally advanced pancreatic ductal adenocarcinoma

Neo-adjuvant chemotherapy plus immunotherapy in resectable N1/N2 NSCLC

Neoadjuvant Chemotherapy Switch in Borderline Resectable/Locally Advanced Pancreatic Cancer

A case study of combined neoadjuvant chemotherapy and neoadjuvant immunotherapy in resectable locally advanced esophageal cancer

Predictive factors of operability after neoadjuvant chemotherapy in resectable or borderline resectable pancreatic cancer: a single-center retrospective study

Preoperative chemotherapy and carbon ions therapy for treatment of resectable and borderline resectable pancreatic adenocarcinoma: a prospective, phase II, multicentre, single-arm study

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Neoadjuvant atezolizumab for resectable non-small cell lung cancer: an open-label, single-arm phase II trial

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Author Correction: Neoadjuvant atezolizumab for resectable non-small cell lung cancer: an open-label, single-arm phase II trial

A multicenter, open-label, single-arm phase I trial of neoadjuvant nivolumab monotherapy for resectable gastric cancer

Perioperative sintilimab and neoadjuvant anlotinib plus chemotherapy for resectable non-small-cell lung cancer: a multicentre, open-label, single-arm, phase 2 trial (TD-NeoFOUR trial)

Neoadjuvant relatlimab and nivolumab in resectable melanoma

Adjuvant and Neoadjuvant Treatments for Resectable Hepatocellular Carcinoma

Neoadjuvant radiotherapy for resectable retroperitoneal sarcoma: a meta-analysis

Network meta-analysis comparing neoadjuvant chemoradiation, neoadjuvant chemotherapy and upfront surgery in patients with resectable, borderline resectable, and locally advanced pancreatic ductal adenocarcinoma

Neo-adjuvant chemotherapy plus immunotherapy in resectable N1/N2 NSCLC

Neoadjuvant Chemotherapy Switch in Borderline Resectable/Locally Advanced Pancreatic Cancer

A case study of combined neoadjuvant chemotherapy and neoadjuvant immunotherapy in resectable locally advanced esophageal cancer

Predictive factors of operability after neoadjuvant chemotherapy in resectable or borderline resectable pancreatic cancer: a single-center retrospective study

Preoperative chemotherapy and carbon ions therapy for treatment of resectable and borderline resectable pancreatic adenocarcinoma: a prospective, phase II, multicentre, single-arm study

Author Correction: Neoadjuvant atezolizumab for resectable non-small cell lung cancer: an open-label, single-arm phase II trial

A multicenter, open-label, single-arm phase I trial of neoadjuvant nivolumab monotherapy for resectable gastric cancer

Perioperative sintilimab and neoadjuvant anlotinib plus chemotherapy for resectable non-small-cell lung cancer: a multicentre, open-label, single-arm, phase 2 trial (TD-NeoFOUR trial)

Neoadjuvant relatlimab and nivolumab in resectable melanoma

Adjuvant and Neoadjuvant Treatments for Resectable Hepatocellular Carcinoma

Neoadjuvant radiotherapy for resectable retroperitoneal sarcoma: a meta-analysis

Network meta-analysis comparing neoadjuvant chemoradiation, neoadjuvant chemotherapy and upfront surgery in patients with resectable, borderline resectable, and locally advanced pancreatic ductal adenocarcinoma

Neo-adjuvant chemotherapy plus immunotherapy in resectable N1/N2 NSCLC

Neoadjuvant Chemotherapy Switch in Borderline Resectable/Locally Advanced Pancreatic Cancer

A case study of combined neoadjuvant chemotherapy and neoadjuvant immunotherapy in resectable locally advanced esophageal cancer

Predictive factors of operability after neoadjuvant chemotherapy in resectable or borderline resectable pancreatic cancer: a single-center retrospective study

Preoperative chemotherapy and carbon ions therapy for treatment of resectable and borderline resectable pancreatic adenocarcinoma: a prospective, phase II, multicentre, single-arm study

Author Correction: Neoadjuvant atezolizumab for resectable non-small cell lung cancer: an open-label, single-arm phase II trial

A multicenter, open-label, single-arm phase I trial of neoadjuvant nivolumab monotherapy for resectable gastric cancer

Perioperative sintilimab and neoadjuvant anlotinib plus chemotherapy for resectable non-small-cell lung cancer: a multicentre, open-label, single-arm, phase 2 trial (TD-NeoFOUR trial)

Neoadjuvant relatlimab and nivolumab in resectable melanoma

Adjuvant and Neoadjuvant Treatments for Resectable Hepatocellular Carcinoma

Neoadjuvant radiotherapy for resectable retroperitoneal sarcoma: a meta-analysis

Network meta-analysis comparing neoadjuvant chemoradiation, neoadjuvant chemotherapy and upfront surgery in patients with resectable, borderline resectable, and locally advanced pancreatic ductal adenocarcinoma

Neo-adjuvant chemotherapy plus immunotherapy in resectable N1/N2 NSCLC

Neoadjuvant Chemotherapy Switch in Borderline Resectable/Locally Advanced Pancreatic Cancer

A case study of combined neoadjuvant chemotherapy and neoadjuvant immunotherapy in resectable locally advanced esophageal cancer

Predictive factors of operability after neoadjuvant chemotherapy in resectable or borderline resectable pancreatic cancer: a single-center retrospective study

Preoperative chemotherapy and carbon ions therapy for treatment of resectable and borderline resectable pancreatic adenocarcinoma: a prospective, phase II, multicentre, single-arm study

Related objects

Reset password